Alzheimer's Disease Treatments Market - Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: A513FA45083EEN
Market Monitor Global

Abstracts

Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time.

This report contains market size and forecasts of Alzheimer's Disease Treatments in Global, including the following market information:

Global Alzheimer's Disease Treatments Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Alzheimer's Disease Treatments market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cholinesterase Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Alzheimer's Disease Treatments include Eisai, Forest Laboratories, H. Lundbeck, Johnson and Johnson, Merz Pharma, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer's Disease Treatments companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Alzheimer's Disease Treatments Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer's Disease Treatments Market Segment Percentages, by Type, 2021 (%)

• Cholinesterase Inhibitors
• NMDA Antagonists

Global Alzheimer's Disease Treatments Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Alzheimer's Disease Treatments Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Diagnostic Laboratories
• Research and Academic Laboratories
• Others

Global Alzheimer's Disease Treatments Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Alzheimer's Disease Treatments Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Alzheimer's Disease Treatments revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Alzheimer's Disease Treatments revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eisai
• Forest Laboratories
• H. Lundbeck
• Johnson and Johnson
• Merz Pharma
• Novartis
• Pfizer

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Alzheimer's Disease Treatments Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Alzheimer's Disease Treatments Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ALZHEIMER'S DISEASE TREATMENTS OVERALL MARKET SIZE

2.1 Global Alzheimer's Disease Treatments Market Size: 2021 VS 2028
2.2 Global Alzheimer's Disease Treatments Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Alzheimer's Disease Treatments Players in Global Market
3.2 Top Global Alzheimer's Disease Treatments Companies Ranked by Revenue
3.3 Global Alzheimer's Disease Treatments Revenue by Companies
3.4 Top 3 and Top 5 Alzheimer's Disease Treatments Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alzheimer's Disease Treatments Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alzheimer's Disease Treatments Players in Global Market
  3.6.1 List of Global Tier 1 Alzheimer's Disease Treatments Companies
  3.6.2 List of Global Tier 2 and Tier 3 Alzheimer's Disease Treatments Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Alzheimer's Disease Treatments Market Size Markets, 2021 & 2028
  4.1.2 Cholinesterase Inhibitors
  4.1.3 NMDA Antagonists
4.2 By Type - Global Alzheimer's Disease Treatments Revenue & Forecasts
  4.2.1 By Type - Global Alzheimer's Disease Treatments Revenue, 2017-2022
  4.2.2 By Type - Global Alzheimer's Disease Treatments Revenue, 2023-2028
  4.2.3 By Type - Global Alzheimer's Disease Treatments Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Alzheimer's Disease Treatments Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Diagnostic Laboratories
  5.1.4 Research and Academic Laboratories
  5.1.5 Others
5.2 By Application - Global Alzheimer's Disease Treatments Revenue & Forecasts
  5.2.1 By Application - Global Alzheimer's Disease Treatments Revenue, 2017-2022
  5.2.2 By Application - Global Alzheimer's Disease Treatments Revenue, 2023-2028
  5.2.3 By Application - Global Alzheimer's Disease Treatments Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Alzheimer's Disease Treatments Market Size, 2021 & 2028
6.2 By Region - Global Alzheimer's Disease Treatments Revenue & Forecasts
  6.2.1 By Region - Global Alzheimer's Disease Treatments Revenue, 2017-2022
  6.2.2 By Region - Global Alzheimer's Disease Treatments Revenue, 2023-2028
  6.2.3 By Region - Global Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Alzheimer's Disease Treatments Revenue, 2017-2028
  6.3.2 US Alzheimer's Disease Treatments Market Size, 2017-2028
  6.3.3 Canada Alzheimer's Disease Treatments Market Size, 2017-2028
  6.3.4 Mexico Alzheimer's Disease Treatments Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Alzheimer's Disease Treatments Revenue, 2017-2028
  6.4.2 Germany Alzheimer's Disease Treatments Market Size, 2017-2028
  6.4.3 France Alzheimer's Disease Treatments Market Size, 2017-2028
  6.4.4 U.K. Alzheimer's Disease Treatments Market Size, 2017-2028
  6.4.5 Italy Alzheimer's Disease Treatments Market Size, 2017-2028
  6.4.6 Russia Alzheimer's Disease Treatments Market Size, 2017-2028
  6.4.7 Nordic Countries Alzheimer's Disease Treatments Market Size, 2017-2028
  6.4.8 Benelux Alzheimer's Disease Treatments Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Alzheimer's Disease Treatments Revenue, 2017-2028
  6.5.2 China Alzheimer's Disease Treatments Market Size, 2017-2028
  6.5.3 Japan Alzheimer's Disease Treatments Market Size, 2017-2028
  6.5.4 South Korea Alzheimer's Disease Treatments Market Size, 2017-2028
  6.5.5 Southeast Asia Alzheimer's Disease Treatments Market Size, 2017-2028
  6.5.6 India Alzheimer's Disease Treatments Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Alzheimer's Disease Treatments Revenue, 2017-2028
  6.6.2 Brazil Alzheimer's Disease Treatments Market Size, 2017-2028
  6.6.3 Argentina Alzheimer's Disease Treatments Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Alzheimer's Disease Treatments Revenue, 2017-2028
  6.7.2 Turkey Alzheimer's Disease Treatments Market Size, 2017-2028
  6.7.3 Israel Alzheimer's Disease Treatments Market Size, 2017-2028
  6.7.4 Saudi Arabia Alzheimer's Disease Treatments Market Size, 2017-2028
  6.7.5 UAE Alzheimer's Disease Treatments Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eisai
  7.1.1 Eisai Corporate Summary
  7.1.2 Eisai Business Overview
  7.1.3 Eisai Alzheimer's Disease Treatments Major Product Offerings
  7.1.4 Eisai Alzheimer's Disease Treatments Revenue in Global Market (2017-2022)
  7.1.5 Eisai Key News
7.2 Forest Laboratories
  7.2.1 Forest Laboratories Corporate Summary
  7.2.2 Forest Laboratories Business Overview
  7.2.3 Forest Laboratories Alzheimer's Disease Treatments Major Product Offerings
  7.2.4 Forest Laboratories Alzheimer's Disease Treatments Revenue in Global Market (2017-2022)
  7.2.5 Forest Laboratories Key News
7.3 H. Lundbeck
  7.3.1 H. Lundbeck Corporate Summary
  7.3.2 H. Lundbeck Business Overview
  7.3.3 H. Lundbeck Alzheimer's Disease Treatments Major Product Offerings
  7.3.4 H. Lundbeck Alzheimer's Disease Treatments Revenue in Global Market (2017-2022)
  7.3.5 H. Lundbeck Key News
7.4 Johnson and Johnson
  7.4.1 Johnson and Johnson Corporate Summary
  7.4.2 Johnson and Johnson Business Overview
  7.4.3 Johnson and Johnson Alzheimer's Disease Treatments Major Product Offerings
  7.4.4 Johnson and Johnson Alzheimer's Disease Treatments Revenue in Global Market (2017-2022)
  7.4.5 Johnson and Johnson Key News
7.5 Merz Pharma
  7.5.1 Merz Pharma Corporate Summary
  7.5.2 Merz Pharma Business Overview
  7.5.3 Merz Pharma Alzheimer's Disease Treatments Major Product Offerings
  7.5.4 Merz Pharma Alzheimer's Disease Treatments Revenue in Global Market (2017-2022)
  7.5.5 Merz Pharma Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Alzheimer's Disease Treatments Major Product Offerings
  7.6.4 Novartis Alzheimer's Disease Treatments Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Pfizer
  7.7.1 Pfizer Corporate Summary
  7.7.2 Pfizer Business Overview
  7.7.3 Pfizer Alzheimer's Disease Treatments Major Product Offerings
  7.7.4 Pfizer Alzheimer's Disease Treatments Revenue in Global Market (2017-2022)
  7.7.5 Pfizer Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Alzheimer's Disease Treatments Market Opportunities & Trends in Global Market
Table 2. Alzheimer's Disease Treatments Market Drivers in Global Market
Table 3. Alzheimer's Disease Treatments Market Restraints in Global Market
Table 4. Key Players of Alzheimer's Disease Treatments in Global Market
Table 5. Top Alzheimer's Disease Treatments Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alzheimer's Disease Treatments Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alzheimer's Disease Treatments Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alzheimer's Disease Treatments Product Type
Table 9. List of Global Tier 1 Alzheimer's Disease Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alzheimer's Disease Treatments Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Alzheimer's Disease Treatments Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alzheimer's Disease Treatments Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alzheimer's Disease Treatments Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Alzheimer's Disease Treatments Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alzheimer's Disease Treatments Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alzheimer's Disease Treatments Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Alzheimer's Disease Treatments Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alzheimer's Disease Treatments Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alzheimer's Disease Treatments Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alzheimer's Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alzheimer's Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alzheimer's Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alzheimer's Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alzheimer's Disease Treatments Revenue, (US$, Mn), 2023-2028
Table 30. Eisai Corporate Summary
Table 31. Eisai Alzheimer's Disease Treatments Product Offerings
Table 32. Eisai Alzheimer's Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 33. Forest Laboratories Corporate Summary
Table 34. Forest Laboratories Alzheimer's Disease Treatments Product Offerings
Table 35. Forest Laboratories Alzheimer's Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 36. H. Lundbeck Corporate Summary
Table 37. H. Lundbeck Alzheimer's Disease Treatments Product Offerings
Table 38. H. Lundbeck Alzheimer's Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 39. Johnson and Johnson Corporate Summary
Table 40. Johnson and Johnson Alzheimer's Disease Treatments Product Offerings
Table 41. Johnson and Johnson Alzheimer's Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 42. Merz Pharma Corporate Summary
Table 43. Merz Pharma Alzheimer's Disease Treatments Product Offerings
Table 44. Merz Pharma Alzheimer's Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Alzheimer's Disease Treatments Product Offerings
Table 47. Novartis Alzheimer's Disease Treatments Revenue (US$, Mn), (2017-2022)
Table 48. Pfizer Corporate Summary
Table 49. Pfizer Alzheimer's Disease Treatments Product Offerings
Table 50. Pfizer Alzheimer's Disease Treatments Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Alzheimer's Disease Treatments Segment by Type in 2021
Figure 2. Alzheimer's Disease Treatments Segment by Application in 2021
Figure 3. Global Alzheimer's Disease Treatments Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alzheimer's Disease Treatments Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alzheimer's Disease Treatments Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alzheimer's Disease Treatments Revenue in 2021
Figure 8. By Type - Global Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 12. US Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 16. Germany Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 17. France Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 24. China Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 28. India Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 30. Brazil Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alzheimer's Disease Treatments Revenue Market Share, 2017-2028
Figure 33. Turkey Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alzheimer's Disease Treatments Revenue, (US$, Mn), 2017-2028
Figure 37. Eisai Alzheimer's Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Forest Laboratories Alzheimer's Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. H. Lundbeck Alzheimer's Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson and Johnson Alzheimer's Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merz Pharma Alzheimer's Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Alzheimer's Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pfizer Alzheimer's Disease Treatments Revenue Year Over Year Growth (US$, Mn) & (2017-2022)